Sarepta Therapeutics (NASDAQ: SRPT) is active after Rick Barry filed a 13D showing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

13Ds

Baird Upgrades Sarepta Therapeutic (SRPT) to Outperform; Favorable Risk/RewardMay 6, 2015 6:10 AM Form SC 13D Sarepta Therapeutics, Filed by: Barry RichardMay 5, 2015 3:44 PM Point72 Asset Management, L.P. Raises Stake in Sarepta Therapeutics (SRPT) to 5.3%May 1, 2015 4:21 PM